Overview
Immunosuppressants Market Data Product Overview
The Immunosuppressants Market is estimated at USD 48.65 billion in 2025, with the market projected to reach USD 98.70 billion by 2030 at a CAGR of 15.2% from 2025–2030. The report analyzes market growth across drug class, application, distribution channel, and geography, with coverage of North America, Europe, Asia-Pacific, and Rest of the World (RoW). The research incorporates primary interviews with industry experts and secondary research from proprietary databases and industry sources. The file-based product is delivered in PDF / Excel format and includes market sizing, forecasts, segment analysis, geographical insights, and key-player developments.
Use Cases
-
Market entry sizing: Assess the 2024–2030 market trajectory and 15.2% CAGR to support entry and expansion planning in the immunosuppressants industry.
-
Segment opportunity analysis: Compare calcineurin inhibitors, mTOR inhibitors, antimetabolites, corticosteroids, monoclonal antibodies, and other drug classes across organ transplantation, autoimmune disorders, and non-autoimmune inflammatory diseases.
-
Regional strategy development: Evaluate market drivers across North America, Europe, Asia-Pacific, and Rest of the World, including the role of increasing transplant procedures and autoimmune disease prevalence.
-
Competitive and vendor evaluation: Review strategic developments involving key players, including Novartis and Astellas, and assess innovation activity in biologics, targeted therapies, and personalized medicine.
Metadata
Update Frequency: One-time syndicated research
Data Source(s): Primary interviews + secondary research (proprietary databases, industry journals)
Original Publisher of Data: Next Move Strategy Consulting
Geographic Coverage: North America, Europe, Asia-Pacific, and Rest of the World (RoW), including Latin America, Middle East, and Africa
Time Period Coverage: 2024–2030
Is Historical Data “Point-in-Time”: Historical figures are point-in-time as of publication; forecast years are projections
Data Set(s) Format(s): PDF / Excel
Raw or Scraped Data: No — syndicated analyst research
Key Fields: Market size, forecast, CAGR, drug class segmentation, application segmentation, distribution channel segmentation, regional analysis, competitive developments
Number of Companies/Brands Covered: 15 Companies
Key Data Points
- Estimated market size is USD 48.65 billion in 2025.
- Market size is projected to reach USD 98.70 billion by 2030.
- Market CAGR is 15.2% from 2025–2030.
- India performed 18,900 organ transplants in 2024, as cited in the report's Asia-Pacific analysis.
Pricing Information
Next Move Strategy Consulting may offer different licensing options for the report. Subscribers should inquire for tier-specific pricing.
Regulatory and Compliance Information
This report is built from aggregated, publicly available, and licensed secondary sources plus expert interviews conducted on an aggregated basis. It contains no individually identifiable personal data.
Subscription Verification
AWS Data Exchange requires subscription verification on all public offers (subscribers confirm they're not in a restricted country or a covered party).
Highlights
- The Immunosuppressants Market is estimated to reach USD 98.70 billion by 2030 at a CAGR of 15.2% from 2025–2030. The product covers drug classes including calcineurin inhibitors, mTOR inhibitors, antimetabolites, corticosteroids, monoclonal antibodies, and others, supporting market sizing and segment-level analysis.
- The report analyzes applications across organ transplantation, autoimmune disorders, and non-autoimmune inflammatory diseases, with distribution channels spanning hospital, retail, and online pharmacies. Geographic coverage includes North America, Europe, Asia-Pacific, and Rest of the World, supporting regional market assessment and strategic planning.
- The research incorporates primary interviews with industry experts and secondary research from proprietary databases and industry sources. It also tracks strategic developments involving companies including Novartis and Astellas, alongside trends in biologics, targeted therapies, and personalized medicine relevant to the immunosuppressants market.
Details
Features and programs
Financing for AWS Marketplace purchases
Pricing
Custom pricing options
How can we make this page better?
Legal
Content disclaimer
Delivery details
AWS Data Exchange (ADX)
AWS Data Exchange is a service that helps AWS easily share and manage data entitlements from other organizations at scale.
Additional details
You will receive access to the following data sets.
Data set name | Type | Historical revisions | Future revisions | Sensitive information | Data dictionaries | Data samples |
|---|---|---|---|---|---|---|
NMSC_MarketResearch | All historical revisions | All future revisions | Not included | Not included |